OMX Solutions Pty Ltd custom-made medical device, the OMX Craniofacial Fixation Plate, gains inclusion on the Australian Register of Therapeutic Goods
25 February 2020 OMX Solutions Pty Ltd is pleased to announce the Australian regulatory approval of its latest custom-made medical device (CMMDs), the OMX Craniofacial Fixation Plate Kit. A CMMD is a one-off medical device prescribed for the…
Read MoreChanges to AusBiotech Board, including new Chair
25 Feb 2020 AusBiotech has announced that a new Chair has been appointed to its Board following the decision of its current long-serving Chair, Julie Phillips, CEO, BioDiem, to step down from the AusBiotech Board. Michelle Burke, Principal…
Read MoreFunding boost welcomed for hepatitis C rapid diagnostic: Burnet Institute
18 February, 2020 A Burnet project developing a rapid diagnostic test for hepatitis C received a major boost after being awarded funding through the Victorian Medical Research Acceleration Fund (VMRAF). The project, which will speed up access to…
Read MoreNew front opened in fight against common cancer driver
20 February 2020 Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells. A new vulnerability in lymphomas driven by MYC has…
Read MoreHow the brain’s immune system could be harnessed to improve memory
11 February 2020 Story: Gosia Kaszubska, for RMIT When it comes to memory, immune cells are known as the “bad cops” of the brain. But new research shows they could also be turned into “good cops” to power memory…
Read MoreHumanitarian Award to support HMHB: Burnet Institute
19 February, 2020 Image: Mark Sullivan (left) with Burnet Institute Director and CEO, Professor Brendan Crabb AC Two pioneering Australians, acknowledged for their contribution to end the debilitating disease river blindness, have generously dedicated the prize money from…
Read MoreMale fertility: The biological clock ticks for men, too, and affects IVF success
18 February 2020 From Monash University’s LENS Professor Beverley Vollenhoven is talking about making babies. She’s a fertility expert from Monash IVF, and Monash University’s deputy head of obstetrics and gynaecology. Usually in her line of work she’s…
Read MoreOverseas grant pivotal to scientist’s immune therapy project
17 February 2020 Expertise, 20 years of experience in her field and a left-of-field idea have helped Monash Biomedicine Discovery Institute (BDI) Associate Professor Meredith O’Keeffe gain a $500,000 Worldwide Cancer Research grant. The grant, spread over three years and…
Read MoreNovel stem cell approach restores motor function in Parkinson’s Disease
20 February 2020 In a remarkable approach to combatting neurodegeneration using stem cells, Florey researchers have achieved preclinical evidence that stem cells grafts can restore motor function in animals with Parkinson’s Disease. Led by Professor Clare Parish, Head…
Read MoreNew report on stimulating business innovation investment
20 February 2020 Modern Australian businesses are diversifying their approach to innovation, beyond research and development (R&D). These businesses experience higher revenue and job growth and are more likely to survive, says the Stimulating Business Investment in Innovation…
Read More‘Eureka LIVE’ offers exclusive access to global Medtronic network for local companies: Medtronic seeking partners in innovation
20 February 2020 Note: Due to COVID-19 AusMedTech (and Eureka Live) has been postponed until May 2021. Sydney – 20 February 2020 – Medtronic Australasia is calling for companies across Australia and New Zealand to apply to Eureka…
Read MoreImmutep Reports Positive TACTI-002 Data
19 February 2020 SYDNEY, AUSTRALIA – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces interim data from its ongoing Phase II TACTI-002 study.…
Read More
